Phase 1 Retinopathy of Prematurity Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

Safety, PK and PD of FLQ-101 in Premature Neonates

Retinopathy of Prematurity (ROP)

FELIQS INC.18 enrolled1 locationNCT07093255

Recruiting

Phase 1

Pharmacokinetics and Safety of Dexamethasone Eye Drops in Preterm Infants

Retinopathy of Prematurity

Region Skane15 enrolled2 locationsNCT05387941